Search research articles
Contact Us
Filters
Showing results (291-300 of 313) with videos related to
Page
of 32
Sort By:
Annals of Internal Medicine
|
February 26, 2024
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2
Catharine I Paules, Jing Wang, Kay M Tomashek, et al.
Plos Pathogens
|
June 23, 2023
Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens
Huntly M Morrison, Julia Craft, Rafael Rivera-Lugo, et al.
Veterinary Parasitology
|
June 19, 2014
Zoonotic protozoa in the marine environment: a threat to aquatic mammals and public health
M E Olson, A Appelbee, L Measures, et al.
Science Translational Medicine
|
December 5, 2014
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
Ray Y Chen, Lori E Dodd, Myungsun Lee, et al.
Antimicrobial Agents and Chemotherapy
|
June 5, 2013
Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis
Matthew W Carroll, Doosoo Jeon, James M Mountz, et al.
The Journal of Infectious Diseases
|
April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir
Kanal Singh, Kevin Rubenstein, Viviane Callier, et al.
Nature Communications
|
July 6, 2017
SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits
Guillaume M Hautbergue, Lydia M Castelli, Laura Ferraiuolo, et al.
Nature Medicine
|
September 6, 2016
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
Stephanus T Malherbe, Shubhada Shenai, Katharina Ronacher, et al.
Gates Open Research
|
March 13, 2018
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial
Ray Y Chen, Laura E Via, Lori E Dodd, et al.
Open Forum Infectious Diseases
|
May 19, 2023
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections
Daniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 313) with videos related to
Sort By:
Page
of 32
Annals of Internal Medicine
|
February 26, 2024
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2
Catharine I Paules, Jing Wang, Kay M Tomashek, et al.
Plos Pathogens
|
June 23, 2023
Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens
Huntly M Morrison, Julia Craft, Rafael Rivera-Lugo, et al.
Veterinary Parasitology
|
June 19, 2014
Zoonotic protozoa in the marine environment: a threat to aquatic mammals and public health
M E Olson, A Appelbee, L Measures, et al.
Science Translational Medicine
|
December 5, 2014
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
Ray Y Chen, Lori E Dodd, Myungsun Lee, et al.
Antimicrobial Agents and Chemotherapy
|
June 5, 2013
Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis
Matthew W Carroll, Doosoo Jeon, James M Mountz, et al.
The Journal of Infectious Diseases
|
April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir
Kanal Singh, Kevin Rubenstein, Viviane Callier, et al.
Nature Communications
|
July 6, 2017
SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits
Guillaume M Hautbergue, Lydia M Castelli, Laura Ferraiuolo, et al.
Nature Medicine
|
September 6, 2016
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
Stephanus T Malherbe, Shubhada Shenai, Katharina Ronacher, et al.
Gates Open Research
|
March 13, 2018
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial
Ray Y Chen, Laura E Via, Lori E Dodd, et al.
Open Forum Infectious Diseases
|
May 19, 2023
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections
Daniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, et al.
Page
of 32